Position in MRK
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$10,019,659
+$551,994 QoQ
Shares Held
77,974
-0.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#745
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NIXON PEABODY TRUST CO holds $47,887,604 across 9 Drug Manufacturers - General names. MRK ranks #2 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,298 | $19,548,311 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
77,974 | $10,019,659 | |
| 3 | AZN |
Astrazeneca PLC
|
42,186 | $7,999,309 | |
| 4 | JNJ |
Johnson & Johnson
|
22,335 | $5,672,419 | |
| 5 | ABBV |
AbbVie Inc.
|
8,249 | $2,075,778 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
11,564 | $1,460,995 | |
| 7 | AMGN |
Amgen Inc
|
1,381 | $500,087 | |
| 8 | NVS |
Novartis AG
|
2,136 | $334,753 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,019,659 | 77,974 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $9,467,665 | 78,707 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $8,431,010 | 80,097 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $6,737,816 | 80,279 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $6,422,250 | 81,130 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $7,361,845 | 82,017 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $8,357,314 | 84,010 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $9,335,654 | 82,209 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $10,221,051 | 82,561 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $9,317,913 | 70,617 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $7,444,975 | 68,290 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $254,801 | 2,475 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $342,708 | 2,970 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $315,978 | 2,970 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $547,760 | 4,937 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $421,557 | 4,895 | Shares | Sole | 2023-03-15 | |
| 2022-06-30 | $4,544,733 | 49,849 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,139,340 | 50,449 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,044,599 | 52,774 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,274,780 | 30,286 | Shares | Other | 2021-11-04 | |
| 2021-06-30 | $2,162,861 | 27,811 | Shares | Other | 2021-07-30 | |
| 2021-03-31 | $2,151,505 | 27,909 | Shares | Other | 2021-04-26 | |
| 2020-12-31 | $2,256,778 | 27,589 | Shares | Other | 2021-02-10 | |
| 2020-09-30 | $639,212 | 7,706 | Shares | Other | 2020-11-03 | |
| 2020-06-30 | $595,905 | 7,706 | Shares | Other | 2020-08-13 | |
| 2020-03-31 | $612,518 | 7,961 | Shares | Other | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||